Our data emphasize that determining the endogenous DNA methylation status of IRAK1-DMR and expression in PCa is of potential value in predicting the ability of PCa cells to activate IRAK1 and should be considered in setting up individualized PCa treatment algorithms in the clinic. Here, IRAK1 is linked to posterior cortical atrophy.